skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hello, What do you think of BBBY? Although it has had a recent significant rise, I believe that it still trades below book value and the company is aggressively buying back stock. . It seems to be transitioning from brick to online and is still profitable albeit with decreasing metrics. Could you also tell me what was the short position last October and what it is nowadays. Do you know when they report next? Merci.
Read Answer Asked by Yves on February 19, 2019
Q: https://www.theatlas.com/charts/S1mAAANEz

Warren Buffet has not outperformed the S and P 500 in years.

He is nice, loves TV appearances but buy the S and P 500.
Read Answer Asked by ian on February 19, 2019
Q: Hi Peter,

I'd like your opinion of these US stocks based on the data available to you.

Could you name three other high-growth US stocks that pique your interest at current levels?
Read Answer Asked by David on February 19, 2019
Q: I am disappointed in the lower returns of Canadian apartment reits, and can't bring myself to buy Pure Multifamily (RUF.UN) because of the high payout ratio. Are there any US apartment reits that you might suggest I have a look at? I am targeting a dividend of 5% or more.
Thanks!
Read Answer Asked by Paul on February 15, 2019
Q: Hi. I own 2 US stocks, Pfizer and J&J. Have become overweight in J&J so will have some US funds to deploy. I am retired and am a dividend investor with minimum risk. I read with interest your answer to Keith that Verizon and Telus about the same and JPM and Royal Bank similar. You indicated best to invest in areas in the US like Industrials, Tech or large consumer stocks. Appreciate what stocks you recommend in these areas as well as your thoughts on Verizon.

Wayne

Read Answer Asked by Wayne on February 15, 2019
Q: Hello team,

What is wrong with FDA wanting to review CorMedix's "full data set including secondary endpoints from the LOCK-IT-100 study to facilitate FDA's consideration of CorMedix's request to file the New Drug Application (NDA) for Neutrolin on the basis of the LOCK-IT-100 study results."

Why the 27% drop after the meeting with FDA and willingness of the company to provide the data and fully cooperate?

Hold, Sell, or Average down on CRMD?

Thanks as always.
Read Answer Asked by Saeed on February 15, 2019
Q: Hi Team,
I have been averaging up on Google since 2013 and I am currently up 90% and it now accounts for about 8% (in C dollar) of my total portfolio. I am just wondering if I should take some money of the table (my risk tolerance level is above average). Your thoughts on this would be much appreciated.
Cheers,
Read Answer Asked by Harry on February 13, 2019
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!